2009 | Achievement and Award
The prevalence of metabolic syndrome in patents with chronic heart failure is more than twice higher than in normal population in Japan
The nationwide multi-center research group led by Professor
Shimokawa (Tohoku University Graduate School of Medicine) has examined
for the first time the actual prevalence of metabolic syndrome in
patients with chronic heart failure in Japan. As a result, they have
found that the prevalence of metabolic syndrome in patients with
chronic heart failure is 38%, which is more than twice higher than in
normal population in Japan. This research also indicates the importance
of metabolic syndrome in the treatment and prevention of chronic heart
failure, in addition to hypertension, dyslipidemia and diabetes,
emphasizing the
importance of immediate measures for the disorder. This research has
been conducted as a "Comprehensive Research Project on Lifestyle
Disease associated with Cardiovascular Disease (Study fields in
myocardial infarction and stroke) in 2006-2008".
Contact:
Lecturer, Yoshihiro Fukumoto
Tohoku University Hospital
Phone: +81 22-717-7153
